儿童Castleman病2例并文献复习
Two Cases of Castleman Disease in Children and Literature Review
DOI: 10.12677/ACM.2024.143848, PDF,   
作者: 郭淑云, 李学荣*：青岛大学附属医院儿童血液肿瘤科，山东 青岛
关键词: Castleman病；巨大淋巴结；儿童； Castleman Disease； Giant Lymph Nodes； Children
摘要: Castleman病是一种罕见病。现报道2例儿童Castleman病的临床资料，结合文献复习分析Castleman病的发病机制、临床特点、实验室检查以及临床治疗及预后情况，以提高对该病的认识及诊治。
Abstract: Castleman disease is a rare disease. Clinical data of 2 cases of Castleman disease in children were reported. The pathogenesis, clinical features, laboratory examination, clinical treatment and prog-nosis of Castleman disease were analyzed by reviewing literature, so as to improve the understand-ing, diagnosis and treatment of the disease.
文章引用：郭淑云, 李学荣. 儿童Castleman病2例并文献复习[J]. 临床医学进展, 2024, 14(3): 1340-1344. https://doi.org/10.12677/ACM.2024.143848

参考文献

[1] Carbone, A., Borok, M., Damania, B., et al. (2021) Castleman Disease. Nature Reviews Disease Primers, 7, Article No. 84. [Google Scholar] [CrossRef] [PubMed]
[2] Simpson, D. (2018) Epidemiology of Castleman Disease. Hematology/Oncology Clinics of North America, 32, 1-10. [Google Scholar] [CrossRef] [PubMed]
[3] Liu, A.Y., Nabel, C.S., Finkelman, B.S., et al. (2016) Idiopathic Multicentric Castleman’s Disease: A Systematic Literature Review. The Lancet Haematology, 3, E163-E175. [Google Scholar] [CrossRef] 
[4] Parez, N., Bader-Meunier, B., Roy, C.C. and Dommergues, J.P. (1999) Paediatric Castleman Disease: Report of Seven Cases and Review of the Literature. European Journal of Pe-diatrics, 158, 631-637. [Google Scholar] [CrossRef] [PubMed]
[5] Haap, M., Wiefels, J., Horger, M., et al. (2018) Clinical, Laboratory and Imaging Findings in Castleman’s Disease—The Subtype Decides. Blood Reviews, 32, 225-234. [Google Scholar] [CrossRef] [PubMed]
[6] 中华医学会血液学分会淋巴细胞疾病学组, 中国抗癌协会血液肿瘤专业委员会, 中国Castleman病协作组. 中国Castleman病诊断与治疗专家共识(2021年版) [J]. 中华血液学杂志, 2021, 42(7): 529-534.
[7] Borocco, C., Ballot-Schmit, C., Ackermann, O., et al. (2020) The French Paediatric Cohort of Castleman Disease: A Retrospective Report of 23 Patients. Orphanet Journal of Rare Diseases, 15, Article No. 95. [Google Scholar] [CrossRef] [PubMed]
[8] Sopfe, J., Endres, A., Campbell, K., et al. (2019) Castleman Dis-ease in Pediatrics: Insights on Presentation, Treatment, and Outcomes from a Two-Site Retrospective Cohort Study. Pe-diatric Blood & Cancer, 66, e27613. [Google Scholar] [CrossRef] [PubMed]
[9] Chang, K., Wang, Y., Hung, L., et al. (2014) Monoclonality and Cytoge-netic Abnormalities in Hyaline Vascular Castleman Disease. Modern Pathology, 27, 823-831. [Google Scholar] [CrossRef] [PubMed]
[10] Wu, D., Lim, M.S. and Jaffe, E.S. (2018) Pathology of Cas-tleman Disease. Hematology/Oncology Clinics of North America, 32, 37-52. [Google Scholar] [CrossRef] [PubMed]
[11] González García, A., Fernández-Martín, J. and Robles Marhuenda, Á. (2023) Idiopathic Multicentric Castleman Disease and Associated Autoimmune and Autoinflammatory Conditions: Practical Guidance for Diagnosis. Rheumatology, 62, 1426-1435. [Google Scholar] [CrossRef] [PubMed]
[12] Fajgenbaum, D.C., Van Rhee, F. and Nabel, C.S. (2014) HHV-8-Negative, Idiopathic Multicentric Castleman Disease: Novel Insights into Biology, Pathogenesis, and Therapy. Blood, 19, 2924-2933. [Google Scholar] [CrossRef] [PubMed]
[13] Fajgenbaum, D.C. (2018) Novel Insights and Therapeutic Ap-proaches in Idiopathic Multicentric Castleman Disease. Blood, 132, 2323-2330. [Google Scholar] [CrossRef] [PubMed]
[14] Leroy, S., Moshous, D., Cassar, O., et al. (2012) Multicentric Castleman Disease in an HHV-8-Infected Child Born to Consanguineous Parents. Pediatrics, 1, e199-e203. [Google Scholar] [CrossRef] [PubMed]
[15] Farruggia, P., Trizzino, A., Scibetta, N., et al. (2011) Castleman’s Disease in Childhood: Report of Three Cases and Review of the Literature. Italian Journal of Pediatrics, 37, Article No. 50. [Google Scholar] [CrossRef] [PubMed]
[16] Kachur, E., Ang, L.C. and Megyesi, J.F. (2002) Castleman’s Disease and Spinal Cord Compression: Case Report. Neurosurgery, 50, 399-403. [Google Scholar] [CrossRef] 
[17] Fajgenbaum, D.C., Uldrick, T.S., Bagg, A., et al. (2017) International, Evidence-Based Consensus Diagnostic Criteria for HHV-8-Negative/Idiopathic Multicentric Castleman Disease. Blood, 129, 1646-1657. [Google Scholar] [CrossRef] [PubMed]
[18] Van Rhee, F., Oksenhendler, E., Srkalovic, G., et al. (2020) International Evidence-Based Consensus Diagnostic and Treatment Guidelines for Unicentric Castleman Disease. Blood Advances, 4, 6039-6050. [Google Scholar] [CrossRef] [PubMed]
[19] Zhang, M., Jia, M., Chen, J., et al. (2021) UCD with MCD-Like Inflammatory State: Surgical Excision Is Highly Effective. Blood Advances, 5, 122-128. [Google Scholar] [CrossRef] [PubMed]
[20] Talat, N., Belgaumkar, A.P. and Schulte, K. (2012) Sur-gery in Castleman’s Disease. Annals of Surgery, 255, 677-684. [Google Scholar] [CrossRef] 
[21] Mukherjee, S., Martin, R., Sande, B., et al. (2022) Epidemi-ology and Treatment Patterns of Idiopathic Multicentric Castleman Disease in the Era of IL-6-Directed Therapy. Blood Advances, 6, 359-367. [Google Scholar] [CrossRef] [PubMed]
[22] Van Rhee, F., Wong, R.S., Munshi, N., et al. (2014) Sil-tuximab for Multicentric Castleman’s Disease: A Randomised, Double-Blind, Placebo-Controlled Trial. The Lancet On-cology, 15, 966-974. [Google Scholar] [CrossRef] 

为你推荐